glp-1/gip dual agonist mechanism of action Pharmacogenomics Tirzepatide: Genomic Insights into GIP/GLP-1 Response in Type 2 Diabetes and Atherosclerosis Current Insights, Advantages and Challenges
Description
By promoting GLP-1 support, it helps encourage a feeling of fullness, acts as a natural appetite suppressant, and promotes weight loss management when taken before meals
A population-based study from Scandinavia provides some real-world information.
Discover how GLP-1 agonists help improve cardiovascular outcomes independently of glucose control.
Learn about the benefits and savings opportunities of the SmithRx Weight Management Pathway.
In the subgroup analyses, human GLP-1 RAs, but not nonhuman GLP-1 RAs, reduced the risk of MACE in patients with HF (p interaction = 0.11)
Heres what that means for health care
